IMMUNE-MEDIATED HEPATITIS

This adverse event was reported 2044 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED HEPATITIS:

# Drug Count
0 NIVOLUMAB 758
1 PEMBROLIZUMAB 728
2 IPILIMUMAB 540
3 CARBOPLATIN 363
4 PACLITAXEL 260
5 PACLITAXEL (AIBUMIN-BOUND) 218
6 ATEZOLIZUMAB 199
7 BEVACIZUMAB 164
8 DURVALUMAB 131
9 PEMETREXED DISODIUM 128
See all common drugs associated with IMMUNE-MEDIATED HEPATITIS

IMMUNE-MEDIATED HEPATITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TREMELIMUMAB 69 0.0156
1 ETRANACOGENE DEZAPARVOVEC 1 0.0154
2 AVOBENZONE, HOMOSALATE, OCTISALAT, OCTOCRYLENE 2 0.0142
3 AVOBENZONE, HOMOSALATE, OCTOCRYLENE, OCTISALATE 2 0.0134
4 PLATINUM 7 0.0132
5 IPILIMUMAB 540 0.0123
6 TITANIUM DIOXIDE 2 0.0082
7 NIVOLUMAB AND RELATLIMAB-RMBW 4 0.0078
8 NIVOLUMAB 758 0.0077
9 ALUMINUM HYDROXIDE GEL 1 0.0068
See all drugs enriched for association with IMMUNE-MEDIATED HEPATITIS